These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 23000236)
21. In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents. Hsu MS; Liao CH; Liu CY; Yang CJ; Huang YT; Hsueh PR Int J Antimicrob Agents; 2011 Mar; 37(3):276-8. PubMed ID: 21269811 [No Abstract] [Full Text] [Related]
22. Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centers. Gales AC; Sader HS; Fritsche TR Diagn Microbiol Infect Dis; 2008 Apr; 60(4):421-7. PubMed ID: 18068934 [TBL] [Abstract][Full Text] [Related]
23. Favourable outcome in the treatment of carbapenem-resistant Enterobacteriaceae urinary tract infection with high-dose tigecycline. Brust K; Evans A; Plemmons R J Antimicrob Chemother; 2014 Oct; 69(10):2875-6. PubMed ID: 24879666 [No Abstract] [Full Text] [Related]
24. Activity of tigecycline against ESBL-producing and AmpC-hyperproducing Enterobacteriaceae from south-east England. Hope R; Warner M; Potz NA; Fagan EJ; James D; Livermore DM J Antimicrob Chemother; 2006 Dec; 58(6):1312-4. PubMed ID: 17035342 [No Abstract] [Full Text] [Related]
25. In-vitro susceptibility to colistin and tigecycline in New Delhi metallo-beta-lactamase-1 producing Enterobacteriaceae. Chandran SP; Nagaraj S; Kalal BS; Muralidharan S; Macaden R Indian J Med Microbiol; 2013; 31(4):419-20. PubMed ID: 24064660 [No Abstract] [Full Text] [Related]
26. Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005-2009). Sader HS; Farrell DJ; Jones RN Diagn Microbiol Infect Dis; 2011 Feb; 69(2):223-7. PubMed ID: 21251571 [TBL] [Abstract][Full Text] [Related]
27. Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections. Ng SMS; Sioson JSP; Yap JM; Ng FM; Ching HSV; Teo JWP; Jureen R; Hill J; Chia CSB Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):141-148. PubMed ID: 29019016 [TBL] [Abstract][Full Text] [Related]
28. Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance. Pournaras S; Koumaki V; Spanakis N; Gennimata V; Tsakris A Int J Antimicrob Agents; 2016 Jul; 48(1):11-18. PubMed ID: 27256586 [TBL] [Abstract][Full Text] [Related]
32. Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections. Huang SR; Liu MF; Lin CF; Shi ZY J Microbiol Immunol Infect; 2014 Jun; 47(3):187-96. PubMed ID: 23200553 [TBL] [Abstract][Full Text] [Related]
33. In vitro activity of tigecycline against extended-spectrum β-lactamase-producing Enterobacteriaceae and MRSA clinical isolates from Mexico: a multicentric study. Silva-Sanchez J; Reyna-Flores F; Velazquez-Meza ME; Rojas-Moreno T; Benitez-Diaz A; Sanchez-Perez A; Diagn Microbiol Infect Dis; 2011 Jun; 70(2):270-3. PubMed ID: 21596226 [TBL] [Abstract][Full Text] [Related]
34. Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline. Al-Zarouni M; Senok A; Al-Zarooni N; Al-Nassay F; Panigrahi D Med Princ Pract; 2012; 21(6):543-7. PubMed ID: 22722224 [TBL] [Abstract][Full Text] [Related]
35. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient. Rodríguez-Avial C; Rodríguez-Avial I; Merino P; Picazo JJ Clin Microbiol Infect; 2012 Jan; 18(1):61-6. PubMed ID: 21722259 [TBL] [Abstract][Full Text] [Related]
36. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. Garau J Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548 [TBL] [Abstract][Full Text] [Related]